These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Improvement in the treatment of diabetes by means of a portable insulin-infusion apparatus. Preliminary results in 4 unstable juvenile diabetics]. Porr O; Morell B; Walter H; Sturzenegger J; Froesch ER Schweiz Med Wochenschr; 1980 Nov; 110(47):1761-3. PubMed ID: 7006076 [TBL] [Abstract][Full Text] [Related]
9. Continuous intravenous insulin therapy with a miniaturized open-loop system. Renner R; Hepp KD; Mehnert H; Franetzki M Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077 [TBL] [Abstract][Full Text] [Related]
10. [A promising alternative for the treatment of type I diabetes. The implantable insulin pump]. Marescaux J; Vix M; Mutter D; Jeandidier N; Boivin S; Pinget M Chirurgie; 1993-1994; 119(9):579-84; discussion 584-5. PubMed ID: 7729209 [TBL] [Abstract][Full Text] [Related]
11. Experience with long-term peritoneal insulin infusion from external pumps. Selam JL; Slingeneyer A; Saeidi S; Mirouze J; Richard JL; Rodier M; Daynes B; Lapinski H Diabet Med; 1985 Jan; 2(1):41-4. PubMed ID: 2951065 [TBL] [Abstract][Full Text] [Related]
12. A preliminary trial of the programmable implantable medication system for insulin delivery. Saudek CD; Selam JL; Pitt HA; Waxman K; Rubio M; Jeandidier N; Turner D; Fischell RE; Charles MA N Engl J Med; 1989 Aug; 321(9):574-9. PubMed ID: 2761602 [TBL] [Abstract][Full Text] [Related]
13. A portable infusion pump, programmable with 16 rates. Bojsen J; Kølendorf K; Haslev F; Jørgensen K Biotelem Patient Monit; 1978; 5(3):123-33. PubMed ID: 754819 [TBL] [Abstract][Full Text] [Related]
14. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Tamborlane WV; Sherwin RS; Genel M; Felig P Am J Med; 1980 Feb; 68(2):190-6. PubMed ID: 6986766 [TBL] [Abstract][Full Text] [Related]
15. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics. Mayfield RK; Sullivan FM; Colwell JA; Wohltmann HJ Diabetes; 1983 Oct; 32(10):908-14. PubMed ID: 6352376 [TBL] [Abstract][Full Text] [Related]
16. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Guerci B; Floriot M; Böhme P; Durain D; Benichou M; Jellimann S; Drouin P Diabetes Care; 2003 Mar; 26(3):582-9. PubMed ID: 12610005 [TBL] [Abstract][Full Text] [Related]
17. Insulin infusion pumps in the treatment of diabetes. Blackshear PJ Med Instrum; 1982; 16(1):17-9. PubMed ID: 7038411 [TBL] [Abstract][Full Text] [Related]
18. [Effect of octreotide on blood glucose levels in poorly compensated insulin-dependent diabetics on insulin treatment]. Lunetta M; Di Mauro M; Le Moli R Minerva Endocrinol; 1992; 17(1):7-12. PubMed ID: 1495454 [TBL] [Abstract][Full Text] [Related]
19. Long-term implantation of a new implantable programmable insulin pump in two diabetic dogs. Scavini M; Day PW; Eaton RP Artif Organs; 1992 Oct; 16(5):518-22. PubMed ID: 10078304 [TBL] [Abstract][Full Text] [Related]
20. Developmental and application of insulin infusion profiles for therapy of type-I diabetics with portable insulin infusion systems. Schulz G; Strack T; Beyer J; Krause U; Cordes U; Weber T; Nagel J; Beutelspacher F Life Support Syst; 1984; 2(3):189-200. PubMed ID: 6503348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]